Oaktree Acquisition Corp. III Life Sciences Unit

Oaktree Acquisition Corp. III Life Sciences Unit

OACCU
Oaktree Acquisition Corp. III Life Sciences UnitUS flagNASDAQ Global Select
10.93
USD
-0.07
- -
262.37MMarket Cap

Total Valuation

Oaktree Acquisition Corp. III Life Sciences Unit carries a market capitalization of 262.37M, placing it among publicly traded companies globally.

Market Cap262.37M
Enterprise ValueN/A

Share Statistics

Oaktree Acquisition Corp. III Life Sciences Unit currently has 24.58M shares outstanding.

Shares Outstanding24.58M
Owned by Insiders (%)N/A
Owned by Institutions (%)N/A

Valuation Ratios

PE RatioN/A
PS RatioN/A
PB Ratio1.37
P/TBV Ratio1.37
P/FCF RatioN/A
P/OCF RatioN/A

Financial Position

Oaktree Acquisition Corp. III Life Sciences Unit maintains a current ratio of 0.73, meaning it holds 0.7x the short-term assets needed to cover near-term liabilities.

Current Ratio0.73
Quick Ratio0.68
Debt / EquityN/A
Debt / EBITDAN/A
Interest CoverageN/A

Financial Efficiency

Return on Equity (ROE)3.47
Return on Assets (ROA)3.33
Return on Invested Capital (ROIC)N/A
Return on Capital Employed (ROCE)N/A
Revenue Per EmployeeN/A
Employee CountN/A
Inventory TurnoverN/A

Stock Price Statistics

Oaktree Acquisition Corp. III Life Sciences Unit's stock has gained approximately 2.62911% over the past 52 weeks. The 50-day moving average sits at 10.81, while the 200-day moving average is 10.75.

Beta (5Y)N/A
52-Week Price Change2.62911%
50-Day Moving Average10.81
200-Day Moving Average10.75
Average Volume (20 Days)N/A

Income Statement

EBITDA reached -1.20M, while operating income came in at -1.20M.

RevenueN/A
Gross ProfitN/A
Operating Income-1.20M
Pretax Income6.75M
Net Income6.75M
EBITDA-1.20M
EBIT-1.20M
Earnings Per Share (EPS)N/A

Balance Sheet

Total book value stands at 197.79M, with working capital of -469,905.00 providing operational flexibility.

Cash & Cash Equivalents1.18M
Total DebtN/A
Net Debt-1.17M
Equity (Book Value)197.79M
Book Value Per Share8.05
Working Capital-469,905.00

Cash Flow

Oaktree Acquisition Corp. III Life Sciences Unit produced -455,689.00 in operating cash flow over the past twelve months.

Operating Cash Flow-455,689.00
Capital ExpendituresN/A
Free Cash Flow-455,689.00
FCF Per ShareN/A

Scores

Oaktree Acquisition Corp. III Life Sciences Unit posts an Altman Z-Score of 18.47, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score18.47